Free Trial

Nuveen Municipal Income Fund (NMI) Competitors

$9.49 +0.12 (+1.28%)
(As of 12/20/2024 04:33 PM ET)

NMI vs. HQL, MIY, ASG, SAR, MHN, MIN, TPVG, AEF, MMT, and IIF

Should you be buying Nuveen Municipal Income Fund stock or one of its competitors? The main competitors of Nuveen Municipal Income Fund include Abrdn Life Sciences Investors (HQL), BlackRock MuniYield Michigan Quality Fund (MIY), Liberty All-Star Growth Fund (ASG), Saratoga Investment (SAR), BlackRock MuniHoldings New York Quality Fund (MHN), MFS Intermediate Income Trust (MIN), TriplePoint Venture Growth BDC (TPVG), Abrdn Emerging Markets Equity Income Fund (AEF), MFS Multimarket Income Trust (MMT), and Morgan Stanley India Investment Fund (IIF). These companies are all part of the "financial services" industry.

Nuveen Municipal Income Fund vs.

Abrdn Life Sciences Investors (NYSE:HQL) and Nuveen Municipal Income Fund (NYSE:NMI) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, community ranking, earnings, valuation and risk.

Abrdn Life Sciences Investors has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Comparatively, Nuveen Municipal Income Fund has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500.

32.2% of Abrdn Life Sciences Investors shares are held by institutional investors. Comparatively, 16.6% of Nuveen Municipal Income Fund shares are held by institutional investors. 10.1% of Abrdn Life Sciences Investors shares are held by company insiders. Comparatively, 1.0% of Nuveen Municipal Income Fund shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Abrdn Life Sciences InvestorsN/A N/A N/A
Nuveen Municipal Income Fund N/A N/A N/A

In the previous week, Abrdn Life Sciences Investors' average media sentiment score of 0.00 equaled Nuveen Municipal Income Fund'saverage media sentiment score.

Company Overall Sentiment
Abrdn Life Sciences Investors Neutral
Nuveen Municipal Income Fund Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abrdn Life Sciences Investors$86.69M4.26N/AN/AN/A
Nuveen Municipal Income Fund$4.57M20.88N/AN/AN/A

Abrdn Life Sciences Investors pays an annual dividend of $1.86 per share and has a dividend yield of 13.8%. Nuveen Municipal Income Fund pays an annual dividend of $0.43 per share and has a dividend yield of 4.5%.

Abrdn Life Sciences Investors received 79 more outperform votes than Nuveen Municipal Income Fund when rated by MarketBeat users. Likewise, 68.35% of users gave Abrdn Life Sciences Investors an outperform vote while only 61.54% of users gave Nuveen Municipal Income Fund an outperform vote.

CompanyUnderperformOutperform
Abrdn Life Sciences InvestorsOutperform Votes
95
68.35%
Underperform Votes
44
31.65%
Nuveen Municipal Income FundOutperform Votes
16
61.54%
Underperform Votes
10
38.46%

Summary

Abrdn Life Sciences Investors beats Nuveen Municipal Income Fund on 7 of the 8 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NMI vs. The Competition

MetricNuveen Municipal Income FundInvestment offices IndustryFinance SectorNYSE Exchange
Market Cap$94.18M$8.38B$11.28B$19.19B
Dividend Yield4.65%6.75%5.64%3.62%
P/E RatioN/A0.4426.6941.30
Price / Sales20.8814.1636.1617.58
Price / CashN/A7.0318.7121.28
Price / BookN/A0.882.775.32
Net IncomeN/A$73.96M$1.04B$989.88M
7 Day Performance-0.42%-2.96%-2.89%-3.54%
1 Month Performance-0.11%-2.31%-2.90%-3.68%
1 Year Performance3.94%3.73%11.59%12.14%

Nuveen Municipal Income Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMI
Nuveen Municipal Income Fund
N/A$9.49
+1.3%
N/A+4.5%$94.18M$4.57M0.00N/A
HQL
Abrdn Life Sciences Investors
N/A$13.84
flat
N/A+4.0%$378.52MN/A0.00N/A
MIY
BlackRock MuniYield Michigan Quality Fund
N/A$11.67
+0.2%
N/A-0.4%$342.69M$18.58M0.00N/A
ASG
Liberty All-Star Growth Fund
N/A$5.85
+0.3%
N/A+8.7%$340.69M$37.15M0.00N/APositive News
SAR
Saratoga Investment
1.6514 of 5 stars
$24.24
+0.7%
$25.42
+4.9%
-6.7%$334.51M$143.72M15.743,211News Coverage
MHN
BlackRock MuniHoldings New York Quality Fund
N/A$10.66
+0.1%
N/A-3.2%$322.36MN/A0.00N/A
MIN
MFS Intermediate Income Trust
N/A$2.71
flat
N/A-3.6%$308.40MN/A0.00N/AEx-Dividend
TPVG
TriplePoint Venture Growth BDC
0.9697 of 5 stars
$7.23
-7.9%
$7.70
+6.5%
-31.5%$289.55M$24.23M34.76N/AHigh Trading Volume
AEF
Abrdn Emerging Markets Equity Income Fund
N/A$5.46
-0.2%
N/A+7.6%$277.11M$26.30M0.00N/A
MMT
MFS Multimarket Income Trust
N/A$4.73
-0.2%
N/A+1.5%$261.58M$20.10M0.00N/AEx-Dividend
Positive News
IIF
Morgan Stanley India Investment Fund
N/A$26.47
0.0%
N/A+22.7%$259.14MN/A0.00N/APositive News

Related Companies and Tools


This page (NYSE:NMI) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners